Return to Former Activities of Daily Living for Cardiovascular Patients in COVID-19
Article Sidebar
Main Article Content
Downloads
Article Details
Copyright (c) 2021 Cosgun MS, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
WHO. World Health Organization. Link: https://bit.ly/3sdKLFj
Mann R, Perisetti A, Gajendran M, Gandhi Z, Umapathy C, et al. (2020) Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Front Med (Lausanne) 7: 581-521. Link: https://bit.ly/3s7R9xF
WHO. World Health Organization. Link: https://bit.ly/3k59Ejn
Baric RS (2020) Emergence of a Highly Fit SARS-CoV-2 Variant. N Engl J Med 383: 2684-2686. Link: https://bit.ly/3pC5PDD
Johnson KD, Harris C, Cain JK, Hummer C, Goyal H, et al. (2020) Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19. Frontiers in Medicine 7: 526. Link: https://bit.ly/2NGUMvL
Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323: 1239-1242. Link: https://bit.ly/3dp5QbH
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine 382: 1708-1720. Link: https://bit.ly/3uf0QvZ
CfDCaP Centers for Disease Control and Prevention Link: https://bit.ly/3s63Wkc
Chen T, Wu D, Chen H, Yan W, Yang D, et al. (2020) Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368. Link: https://bit.ly/3biX1gM
Du RH, Liu LM, Yin W, Wang W, Guan LL, et al. (2020) Hospitalization and critical care of 109 decedents with COVID-19 pneumonia in Wuhan, China. Ann Am Thorac Soc 17: 839-846. Link: https://bit.ly/3qCgEqq
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, et al. (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA 323: 2052-2059. Link: https://bit.ly/37vYzTz
Zhou F, Yu T, Du R, Fan G, Liu Y, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395: 1054-1062. Link: https://bit.ly/3s94bep
Liang WH, Guan WJ, Li CC, Li YM, Liang HR, et al. (2020) Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J 55: 2000562. Link: https://bit.ly/3pA6yFh
RoTMoH. Republic of Turkey Ministry of Health Link: https://bit.ly/3k5j3rp .
NHP Nottingham Health Profile. Link: https://bit.ly/3k4PIgK
Li N, Zhu L, Sun L, Shao G (2021) The effects of novel coronavirus (SARS-CoV-2) infection on cardiovascular diseases and cardiopulmonary injuries. Stem cell Res 51: 102168. Link: https://bit.ly/3dtnZ8k
Liu Y, Yan LM, Wan L, Xiang TX, Le A, et al. (2020) Viral dynamics in mild and severe cases of COVID-19. Lancet Infectious Dis 20: 656-657. Link: https://bit.ly/3k4Qj1Y
Mendonça CV, Neto JAM, Suzuki FA, Orth MS, Neto HM, et al. (2021) Olfactory dysfunction in COVID-19: a marker of good prognosis? Braz J Otorhinolaryngol S1808-8694(20)30240-8. Link: https://bit.ly/37tzHfe
Sanli DET, Altundag A, Kandemirli SG, Yildirim D, Sanli AN, Saatci O, et al. (2021) Relationship between disease severity and serum IL-6 levels in COVID-19 anosmia. m J Otolaryngol 42: 102796. Link: https://bit.ly/3s9JfE1